vidarabine phosphate has been researched along with Nervous System Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lok, AS; Thomas, HC; Wilson, LA | 1 |
| Cassileth, P; Hochster, H | 1 |
| Berman, E; Warrell, RP | 1 |
| Bissett, J; Eisenberg, M; Garcia, G; Mastre, B; Nair, PV; Roskamp, D; Rosno, S; Smith, CI; Waterman, K; Weissberg, JI | 1 |
2 trial(s) available for vidarabine phosphate and Nervous System Disorders
| Article | Year |
|---|---|
Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Arabinonucleotides; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Muscular Diseases; Nervous System Diseases; Pain; Peripheral Nervous System Diseases; Prospective Studies; Risk; Vidarabine Phosphate | 1984 |
Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Topics: Adult; Arabinonucleotides; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Hepatitis, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Male; Nervous System Diseases; Random Allocation; Vidarabine Phosphate | 1987 |
2 other study(ies) available for vidarabine phosphate and Nervous System Disorders
| Article | Year |
|---|---|
Fludarabine phosphate therapy of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nervous System Diseases; Remission Induction; Survival Rate; Vidarabine Phosphate | 1990 |
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.
Topics: Acute Disease; Adult; Arabinonucleotides; Central Nervous System; Drug Evaluation; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Middle Aged; Nervous System Diseases; Vidarabine Phosphate | 1986 |